Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: APVMA (Australian Pesticides and Veterinary Medicines Authority)
BORDETELLA BRONCHISEPTICA; CANINE PARAINFLUENZA VIRUS; ALUMINIUM HYDROXIDE
INTERVET AUSTRALIA PTY LIMITED
vaccine - canine Bordetella(0.05ug/dose)+vaccine - canine parainfluen
MISC. VACCINES OR ANTI SERA
BORDETELLA BRONCHISEPTICA VACCINE-MICROBIAL Active 0.05 ug/ml; CANINE PARAINFLUENZA VIRUS VACCINE-VIRAL Active 1000000.0 TCI50/ml; ALUMINIUM HYDROXIDE MINERAL-ALUMINIUM-BASE Other 3.0 mg/ml
1 x dose; 10 x dose; 20 x dose; 25 x dose; 5 x dose; 50 x dose
VM - Veterinary Medicine
INTERVET AUSTRALIA
DOG | BITCH | CASTRATE | PUPPY
IMMUNOTHERAPY
BORDETELLA BRONCHISEPTICA | CANINE PARAINFLUENZA | CANINE COUGH SYNDROME | INFECTIOUS TRACHEOBRONCHITIS
Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [BORDETELLA BRONCHISEPTICA, CANINE PARAINFLUENZA]; For the active immunisation of dogs against Bordetella bronchiseptica and canine parainfluenza virus.AVOID USING in dogs receiving corticosteroids or in pregnant bitches. Refer also to Side Effects, etc. on label.
Registered
2023-07-01
For Official Use Only E-LABEL APPLICATION (DRAFT) COMPANY NAME: INTERVET AUSTRALIA PTY LIMITED PRODUCT NAME: NOBIVAC BB/PI ELABEL APPLICATION NO: DC12-62888537E9 APVMA APPROVAL NO: 62433/100831 PRODUCT NO: 62433 VERSION NO: 3.0 APPLICATION STARTED: 2014-Oct-30 11:28:35 VERSION CREATED: 2015-Feb-27 10:40:22 STARTED BY: Lyn Lavidis PRINTED: 2015-Feb-27 14:24:09 LABEL NAME: NOBIVAC BB/PI SIGNAL HEADINGS: FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: ACTIVE CONSTITUENTS: Each single dose contains at least: 0.05 µg purified inactivated Bordetella bronchiseptica antigen10^6 TCID50 inactivated canine parainfluenza virus and 3 mg aluminium hydroxide (adjuvant). CLAIMS: INJECTABLE BIVALENT INACTIVATED VACCINE FOR DOGS For the active immunisation of dogs against Bordetella bronchiseptica and canine parainfluenza virus. NET CONTENTS: single dose vial 10 x single dose vials 20 x single dose vials 25 x single dose vials 5 x single dose vials 50 x single dose vials DIRECTIONS FOR USE: DIRECTIONS FOR USE: Only healthy dogs possessing normal temperatures should be vaccinated. CONTRAINDICATIONS: CONTRAINDICATIONS: This product should not be used in dogs receiving corticosteroids or in pregnant bitches. SIDE EFFECTS: SIDE EFFECTS A local reaction may occur at the inoculation sites in some dogs. DOSAGE AND ADMINISTRATION: DOSAGE AND ADMINISTRATION: Note: The removable label should only be removed after the dose has been given. RLP APPROVED For Official Use Only Under normal circumstances: Primary vaccination: Inject subcutaneously or intramuscularly 2 doses of vaccine at an interval of 1 month to dogs 6 weeks of age or over. Nobivac® Bb/Pi is suitable for use as a diluent with Nobivac® DHP. An annual booster is recommended. GENERAL DIRECTIONS: Due to the interference of maternal antibodies with active immunisation, protection of young puppies can be difficult, especially in infected kennels. Epidemiological conditions and the likely persistence of maternal antibodies (e.g. antibody titres of the mother, age of weaning) can t Đọc toàn bộ tài liệu
PRODUCT NAME: NOBIVAC BB/PI MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JANUARY, 2010 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) CHEMICAL NATURE: Suspension of inactivated viruses in saline. TRADE NAME: NOBIVAC BB/PI RECOMMENDED USE: For protection against Bordetella bronchiseptica and canine parainfluenza in dogs. APVMA NO: 62433 CREATION DATE: January, 2010 THIS VERSION ISSUED: January, 2010 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S23, S25. Do not breathe mists. Avoid contact with eyes. SUSDP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: White or off-white suspension. ODOUR: No data; expected to be almost odourless. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. LONG TERM EXPOSURE: No data for health effects associated with long term skin exposure. EYE CONTACT: SHORT TERM EXPOSURE : This product may be mildly irritating to eyes, but is unlikely to cause anything more than mild discomfort which should disappear once product is removed. LONG TERM EXPOSURE : No data for health Đọc toàn bộ tài liệu